Evidence map›Paper›PMID 42370190›Full record

ReviewTheranostics2026

Biomechanical signaling of cytoskeleton and membrane reorganization in tumor immune chemotactic migration.

Qijie Zhao, Keliang Chen, Minglu Zhou, Jing Jin

Abstract readReview
In one paragraph

Review in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qijie ZhaoDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Keliang ChenDepartment of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Minglu ZhouDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.
Jing JinDepartment of Radiation Oncology, Cancer center, West China Second University Hospital of Sichuan University, Chengdu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A prominent activity of the chemokine system is the regulation of immune cells trafficking in tumor microenvironment (TME). This elegant chemotaxis process is regulated by both chemokine receptors (CKRs) stimulation and intracellular factors, such as chemokine, actin cytoskeleton, cell adhesion molecules, membrane fluidity, metabolic reorganization that govern differences in tumor immune cells migration patterns. At the core of tumor immune cell migration and effector functions are three fundamental questions: how CKR signaling triggers morphological changes, how the interplay between actin/selectin and energy metabolism regulates force production, and how cytoskeletal signaling adapts to membrane fluidity. In this review, we discuss the potential influences of CKRs signaling of the actin/selectin cytoskeleton reorganization, membrane fluidity, force regulation, and metabolic reorganization in immune cell chemotaxis. Apparently, the activity of immune cells migration is not regulated solely by chemokine-receptors recognition, as biomechanical-metabolic signaling orchestrate is critical for migratory morphology regulation. By using current knowledge of general chemotaxis mechanisms as a framework, we hope to provide new insights into secondary changes mechanisms of cytoskeleton and morphology network in supporting the tumor immune cells migration. Unraveling the mechanisms underlying chemotaxis and coupled mechanical immune checkpoints holds immense potential for discovering novel therapeutic targets in cancer immunotherapy.

Indexed as

Cell MembraneChemotaxisCytoskeletonNeoplasmsSignal TransductionAnimalsCell MovementChemokinesHumansReceptors, ChemokineTumor MicroenvironmentChemokinesReceptors, ChemokineActinChemokine receptors (CKRs)ChemotaxisCytoskeletonMetabolic reprograming

Identifiers

PMID42370190
PMCPMC13294973

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.